Skip to main content

Table 2 Characteristics of HIV prevalence (per 10,000) among persons with suspected HIV infection who voluntarily underwent HIV testing and revealed their identity at public health centers in Korea from 2010 to 2015

From: Influence of anonymous HIV testing on national HIV surveillance in the Republic of Korea (2000 to 2015): a retrospective analysis

Category201020112012201320142015
NPrevalenceaORNPrevalenceaORNPrevalenceaORNPrevalenceaORNPrevalenceaORNPrevalenceaOR
(HIV+)(95% CI)(95% CI)(HIV+)(95% CI)(95% CI)(HIV+)(95% CI)(95% CI)(HIV+)(95% CI)(95% CI)(HIV+)(95% CI)(95% CI)(HIV+)(95% CI)(95% CI)
Total39,43018.3 49,66017.12 49,42818.61 52,07922.27 30,72762.16 33,40271.55 
(72)(14.0–22.5) (85)(13.5–20.8) (92)(14.8–22.4) (116)(18.2–26.3) (191)(53.4–70.9) (239)(62.5–80.6) 
Sex
 Female20,7442.1122,9322.1123,4911.3125,5416.3116,0544.4115,3197.81
(4)(25.0–40.6) (5)(0.0–4.2) (3)(0.0–2.7) (16)(3.2–9.3) (7)(1.1–7.6) (12)(3.4–12.3) 
 Male18,68632.819.026,72832.813.825,93734.327.126,53837.76.114,673125.429.518,08369.916.4
(68)(0.0–4.2)(6.9–52.1)(80)(25.0–40.6)(5.6–34.0)(89)(27.2–41.4)(8.6–85.7)(100)(30.3–45.1)(3.6–10.3)(184)(107.4–143.4)(13.9–62.7)(227)(60.9–79.0)(9.2–29.4)
Age Group (y)
  < 2024410046552.20.386523.17.4332231.4156319.21.6193715.50.9
(0)(0.0–0.0)(0.0–0.0)(1)(0.0–6.4)(0.0–2.7)(2)(0.0–55.1)(1.4–40.7)(1)(0.0–8.9)(0.1–15.6)(3)(0.0–40.9)(0.4–7.1)(3)(0.0–33.0)(0.2–3.7)
 20–2913,17117.51.514,67620.42.511,12634.211.015,18531.614.9983991.57.711,39597.45.7
(23)(10.3–24.6)(0.5–4.3)(30)(13.1–27.7)(1.0–6.5)(38)(23.3–45.0)(3.9–30.9)(48)(22.7–40.5)(3.6–61.3)(90)(72.6–110.)(2.8–21.1)(111)(79.4–115.4)(2.3–14.1)
 30–3910,27622.41.910,82019.42.410,68025.38.111,02826.312.4884846.33.9931668.74.0
(23)(13.2–31.5)(0.7–5.5)(21)(11.1–27.7)(0.9–6.3)(27)(15.8–34.8)(2.8–23.3)(29)(16.7–35.9)(3.0–51.9)(41)(32.2–60.5)(1.4–10.8)(64)(51.9–85.5)(1.6–10.0)
 40–496083232.0764027.53.4687417.55.6673434.216.1371983.47.0431288.15.2
(14)(11.0–35.1)(0.6–6.0)(21)(15.7–39.2)(1.3–9.0)(12)(7.6–27.3)(1.8–17.4)(23)(20.2–48.1)(3.8–68.4)(31)(54.1–112.6)(2.5–20.0)(38)(60.2–116.0)(2.0–13.2)
 50–59405119.81.7573212.21.5712212.64.0645820.19.4345763.65.3357350.42.9
(8)(6.1–33.4)(0.5–5.6)(7)(3.2–21.3)(0.5–4.7)(9)(4.4–20.9)(1.3–13.1)(13)(9.2–31.1)(2.1–41.9)(22)(37.1–90.1)(1.8–15.5)(18)(27.2–73.6)(1.1–7.9)
 60≤340911.7161378.2112,7623.1193532.11330112.11287017.42
(4)(0.2–23.2) (5)(1.0–15.3) (4)(0.1–6.2) (2)(0.0–5.1) (4)(0.2–24.0) (5)(2.2–32.7) 
Nationality
 Korean33,87820.1143,32218.7148,04918.5150,57621.4129,69061.3132,32568.11
(68)(15.3–24.8) (81)(14.6–22.8) (89)(14.7–22.4) (108)(17.3–25.4) (182)(52.4–70.2) (220)(59.1–77.0) 
 Foreign55527.20.463386.30.3137921.81.2150353.22.5103786.81.41077176.52.7
(4)(0.1–14.3)(0.1–0.9)(4)(0.1–12.5)(0.1–0.9)(3)(0.0–46.3)(0.4–3.7)(8)(16.4–90.0)(1.2–5.2)(9)(30.3–143.2)(0.7–2.8)(19)(97.8–255.1)(1.7–4.4)
Region
 Metropolis13,18838.74.915,73634.33.811,41952.56.315,18149.44.58882139.64.710,701162.65.8
(51)(28.1–49.3)(2.9–8.1)(54)(25.2–43.5)(2.4–5.9)(60)(39.3–65.8)(4.1–9.7)(75)(38.4–60.6)(3.1–6.6)(124)(115.2–164.0)(3.5–6.3)(174)(138.6–186.6)(4.4–7.8)
 Smaller city or rural area26,2428133,9249.1138,0098.4136,89811.1121,84530.7122,70128.61
(21)(4.6–11.4) (31)(5.9–12.4) (32)(5.5–11.3) (41)(7.7–14.5) (67)(23.3–38.0) (65)(21.7–35.6) 
  1. HIV human immunodeficiency virus, N Number of HIV test takers, HIV+ Number of HIV-infected persons, Prevalence: the number of HIV-infected persons per 10,000 HIV test takers, CI confidence interval, aOR Adjusted odds ratio